Congenica receives investments from BGI, Healthlink and Future Planet
Congenica, a specialist in clinical genomics software for inherited diseases, has completed a Series B funding round with additional investments from BGI Genomics, Healthlink Capital and Future Planet Capital. Alongside investing, BGI Genomics and UniteGen, Healthlink’s associated clinical diagnostic lab, have signed commercial contracts to use Congenica’s proprietary enterprise software,
